Acute Cholangitis — Diagnosis and Early Management

Key Points

• Cholangitis is infection plus biliary obstruction; antibiotics without drainage may fail when pressure and obstruction persist.
• Charcot triad is not sensitive enough to rule out cholangitis.
• Obtain blood cultures in systemically ill patients and start empiric antibiotics promptly when sepsis is present.
• Ultrasound is a useful first test, but CT, MRCP, EUS, or direct ERCP may be needed depending on stability and diagnostic certainty.
• Moderate disease generally requires early biliary drainage; severe disease requires organ support and drainage as soon as feasible after initial stabilization.
• ERCP is the preferred decompression method in most patients, with percutaneous drainage as an important alternative.
• Review prior biliary cultures and instrumentation because resistant organisms are more common in recurrent or health care-associated infection.
• Definitive treatment of stones, strictures, or malignancy should follow initial control of infection and obstruction.

Algorithm

1. Recognize systemic inflammation plus cholestasis or jaundice and suspected biliary obstruction.
2. Assess for shock or organ dysfunction and begin sepsis resuscitation when present.
3. Obtain CBC, liver chemistry, renal function, coagulation studies, lactate when indicated, and blood cultures in significant illness.
4. Perform urgent biliary imaging, usually ultrasound first, while avoiding imaging delays in a patient who clearly requires decompression.
5. Start empiric antibiotics based on severity, prior instrumentation, allergy history, and local antibiogram.
6. Grade severity and obtain urgent gastroenterology or interventional consultation for drainage.
7. Perform ERCP for early or urgent biliary decompression in moderate or severe disease; use percutaneous or surgical drainage if ERCP cannot be performed or fails.
8. Narrow antimicrobials, treat the underlying obstructing lesion, and monitor for recurrent obstruction, bacteremia, pancreatitis, and organ failure.

Clinical Synopsis & Reasoning

Suspect acute cholangitis in a patient with fever or systemic inflammation plus cholestatic laboratory abnormalities and evidence of biliary dilatation or an obstructing lesion. The classic Charcot triad of fever, right upper quadrant pain, and jaundice is specific when present but is not sufficiently sensitive to exclude the diagnosis. Older adults and immunocompromised patients may present primarily with delirium, hypotension, anorexia, or renal dysfunction. Common causes include choledocholithiasis, malignant biliary obstruction, benign stricture, occluded biliary stents, and complications of instrumentation. Initial reasoning should establish whether this is uncomplicated biliary infection or infection under pressure that requires drainage. Obtain a CBC, comprehensive metabolic panel with bilirubin and alkaline phosphatase, lactate when sepsis is suspected, coagulation studies, and blood cultures in patients with systemic illness. Right upper quadrant ultrasonography is a useful first study for ductal dilatation and gallstones, but a normal or nondiagnostic ultrasound does not exclude common bile duct obstruction. Contrast CT can identify alternative diagnoses and complications, while MRCP or endoscopic ultrasonography can define ductal pathology when the patient is stable. ERCP is both diagnostic and therapeutic and should not be delayed for exhaustive imaging in a deteriorating patient with a convincing obstructive syndrome. Severity grading matters because organ dysfunction, persistent hypotension, altered consciousness, respiratory failure, renal failure, hepatic dysfunction, or coagulopathy identifies severe disease and mandates urgent source-control planning.

Treatment Strategy & Disposition

Begin resuscitation immediately in patients with sepsis or organ dysfunction. Give oxygen and ventilatory support as needed, establish IV access, obtain cultures without delaying therapy, and use balanced crystalloid with repeated reassessment when hypoperfusion is present. Start empiric antibiotics that cover enteric gram-negative organisms and streptococci; include enterococcal and resistant gram-negative coverage when health care exposure, prior biliary instrumentation, immunocompromise, or local epidemiology warrants it. Examples include ceftriaxone plus metronidazole for selected community-acquired disease, or piperacillin-tazobactam for more severe or health care-associated infection, with broader regimens guided by local susceptibility patterns. De-escalate when cultures and source information are available. Antibiotics alone are often adequate for mild disease that improves promptly, but they do not reliably sterilize an obstructed biliary tree. Tokyo Guidelines 2018 recommend early biliary drainage for moderate cholangitis and drainage as soon as possible after initial stabilization for severe cholangitis. ERCP is preferred in most patients because it permits decompression, stent placement, sphincterotomy, and stone extraction when appropriate. If ERCP is unavailable or unsuccessful, percutaneous transhepatic drainage or surgical drainage may be required. In a profoundly unstable patient, the immediate objective may be decompression with stenting or nasobiliary drainage, with definitive stone therapy deferred until physiology improves. After successful source control, tailor antibiotic duration to clinical response, bacteremia, organism, and adequacy of drainage rather than extending therapy reflexively.

Epidemiology / Risk Factors

• Choledocholithiasis is a common cause of community-acquired acute cholangitis.
• Malignancy, benign stricture, and biliary stents are important causes in older and medically complex patients.
• Prior ERCP, sphincterotomy, biliary-enteric anastomosis, and repeated antibiotic exposure increase the likelihood of resistant flora.
• Bacteremia is common enough that blood cultures can materially guide therapy in moderate or severe disease.
• Mortality rises sharply when organ dysfunction develops and source control is delayed.

Investigations

Empiric Antibiotic Examples

Pharmacology

Prognosis / Complications

• Mild cholangitis usually improves quickly with antibiotics and relief of obstruction.
• Septic shock, renal failure, coagulopathy, altered mental status, and delayed drainage are associated with worse outcomes.
• Successful biliary decompression often produces rapid improvement in fever, hypotension, and cholestatic markers.
• Recurrence is likely if the obstructing stone, stricture, tumor, or malfunctioning stent is not definitively addressed.
• Patients with malignant obstruction or complex hilar disease often require multidisciplinary follow-up and repeated drainage planning.

Patient Education / Counseling

• Explain that the infection is occurring behind a blockage and that drainage may be as important as antibiotics.
• Advise patients with biliary stents to seek prompt care for recurrent fever, jaundice, rigors, confusion, or dark urine.
• After stone-related cholangitis, discuss definitive gallbladder and bile-duct management to reduce recurrence.
• Review medication changes, antibiotic duration, pending cultures, and any plan for repeat ERCP or stent exchange before discharge.
• Seek emergency care for recurrent jaundice with fever, faintness, worsening abdominal pain, confusion, or inability to maintain hydration.

Notes

The central clinical error in cholangitis is to treat it as ordinary bacteremia while leaving an obstructed infected biliary system under pressure. Improvement in blood pressure or fever after antibiotics does not eliminate the need to assess whether drainage is required. Severity should be reassessed repeatedly because a patient can move from localized biliary infection to septic shock over hours. The safest care pathway combines early antimicrobial therapy, organ support, timely ERCP or alternative decompression, and definitive treatment of the obstructing lesion.

References

1. Tokyo Guidelines 2018: Initial Management of Acute Biliary Infection and Flowchart for Acute Cholangitis — Link
2. Tokyo Guidelines 2018: Antimicrobial Therapy for Acute Cholangitis and Cholecystitis — Link